Amneal Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Amneal Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amneal Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Amneal Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $1.1M | 178k | 6.06 |
2023-12-31 | $1.1M | 174k | 6.07 |
2023-09-30 | $289k | 68k | 4.22 |
2023-06-30 | $37k | 12k | 3.10 |
2023-03-31 | $7.3k | 5.2k | 1.39 |
2022-12-31 | $38k | 19k | 1.99 |
2022-09-30 | $55k | 27k | 2.06 |
2022-06-30 | $35k | 11k | 3.14 |
2022-03-31 | $52k | 12k | 4.19 |
2021-12-31 | $178k | 37k | 4.76 |
2021-09-30 | $59k | 11k | 5.36 |
2021-06-30 | $103k | 20k | 5.09 |
2021-03-31 | $74k | 11k | 6.73 |
2020-12-31 | $246k | 54k | 4.55 |
2020-09-30 | $165k | 42k | 3.91 |
2020-06-30 | $386k | 81k | 4.74 |
2020-03-31 | $43k | 12k | 3.48 |
2019-12-31 | $27k | 5.5k | 4.91 |
2019-09-30 | $22k | 7.6k | 2.88 |
2019-06-30 | $167k | 23k | 7.18 |
2019-03-31 | $562k | 41k | 13.57 |
2018-12-31 | $1.0M | 75k | 13.57 |
2018-09-30 | $954k | 50k | 19.11 |
2018-06-30 | $932k | 57k | 16.42 |